18th Jun 2020 18:49
PureTech Health PLC - Boston, Massachusetts-based biotherapeutics company - Founded entity Gelesis announces partnership for commercial launch of Plenity drug in China with China Medical System Holdings Ltd. CMS to provide USD35 million upfront in combination of licensing fees and equity investment, with potential for an additional USD388 million in future milestone payments as well as royalties.
Current stock price: 274.50 pence
Year-to-date change: down 13%
By Arvind Bhunjun; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
PureTech